Evidence Shows CBD Beneficial for Alzheimer's Disease, Parkinson's Disease, and Multiple Sclerosis

 Photo Credit: Medical Marijuana Inc.

Photo Credit: Medical Marijuana Inc.

According to new research conducted by a team of Italian researchers and published in CNS & Neurological Disorders - Drug Targets, CBD can provide neuroprotection for patients diagnosed with neurological disorders. In the study, researchers looked through laboratory and clinical findings referencing CBD’s effects on neurological conditions, and while more research is left to be desired, they determined, “Pre-clinical evidence largely shows that CBD can produce beneficial effects in [Alzheimer’s disease], [Parkinson’s disease], and [multiple sclerosis] patients, but its employment for these disorders needs further confirmation from well designed clinical studies.” The review only searched through studies involving CBD alone.

This information supports previous studies that suggest CBD has neuroprotective properties that can inhibit the progression of neurological disorders. Additionally, researchers found pre-clinical evidence suggesting CBD has antiepileptic properties and can be effective and beneficial for those diagnosed with treatment-resistant seizure disorders.

This information has been provided by Medical Marijuana Inc. and approved by our Chief Medical Officer. You can also access the review here.